Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-01-09

Clinical Trial Update: EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment [NA]

View source ↗

Summary

BrainQ Technologies is recruiting for EMAGINE 2.0, a clinical trial evaluating electromagnetic field therapy as a novel subacute treatment for ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: BrainQ Technologies Ltd. | Conditions: Ischemic Stroke | NA | Status: RECRUITING